Neglected Tropical Diseases Diagnosis Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
Description
Persistence Market Research has recently published an extensive report on the global Neglected Tropical Diseases Diagnosis Market, delivering a thorough analysis of the market’s key drivers, emerging trends, opportunities, and challenges. This report provides valuable insights to assist stakeholders in making strategic and informed decisions.
Key Insights:
The neglected tropical diseases diagnosis market includes diagnostic technologies and services aimed at identifying various tropical diseases that primarily affect populations in tropical and subtropical regions. These diseases encompass dengue, Chagas disease, leprosy, lymphatic filariasis, and many others. The market features a spectrum of diagnostic methods, including traditional and advanced molecular techniques. Increasing global health initiatives, rising disease prevalence, and advancements in diagnostic solutions are major factors influencing the market’s growth. Expansion of healthcare infrastructure in developing nations further supports the rising demand for effective diagnosis.
Market Growth Drivers:
The global neglected tropical diseases diagnosis market is driven by several important factors. An increasing incidence of neglected tropical diseases in endemic areas has highlighted the need for rapid and accurate diagnostic tools, thereby fueling demand. Additionally, growing funding from governments and international health organizations aimed at disease control and eradication is boosting screening programs worldwide. Technological progress in molecular diagnostics and point-of-care testing enables faster, more reliable disease detection, especially in remote regions. Expansion of healthcare facilities and increased awareness about neglected tropical diseases also contribute significantly to market growth.
Market Restraints:
Despite promising growth, the market faces some challenges. Limited access to healthcare infrastructure and diagnostic laboratories in remote and low-income areas hampers widespread adoption. The relatively high cost of advanced diagnostic equipment poses affordability issues in underdeveloped regions. Moreover, lack of skilled healthcare professionals trained in disease diagnosis and logistical barriers in deploying testing solutions impact market penetration. Underreporting and social stigma surrounding certain diseases lead to underdiagnosis, which limits the overall market potential.
Market Opportunities:
The neglected tropical diseases diagnosis market holds considerable growth opportunities owing to continuous innovation and increasing investments. The development of affordable, portable, and user-friendly point-of-care diagnostic devices provides an avenue to reach underserved populations. Public-private partnerships and global health initiatives focused on eliminating tropical diseases are opening new avenues for market expansion. Emerging diagnostic technologies, such as multiplex assays capable of detecting multiple diseases simultaneously, offer enhanced efficiency. Integration of digital health technologies and artificial intelligence for disease surveillance and diagnostics is also expected to fuel future growth.
Key Questions Answered in the Report:
Top players in the neglected tropical diseases diagnosis market, including F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, and Genome Diagnostics Pvt. Ltd., are actively investing in product innovation and expanding their market reach. These companies are developing cost-effective and rapid diagnostic solutions tailored for use in low-resource settings. They focus on strategic collaborations with government agencies, NGOs, and healthcare providers to broaden distribution. Additionally, strengthening supply chains and enhancing the accuracy and usability of diagnostic tools are key strategic priorities to maintain competitiveness.
Companies Covered in This Report:
By Disease
Please Note: It will take 5 business days to complete the report upon order confirmation.
Key Insights:
- Neglected Tropical Diseases Diagnosis Market Size (2025E): US$ 7,600.0 Mn
- Projected Market Value (2032F): US$ 10,204.8 Mn
- Expected CAGR (2025 to 2032): 4.3%
The neglected tropical diseases diagnosis market includes diagnostic technologies and services aimed at identifying various tropical diseases that primarily affect populations in tropical and subtropical regions. These diseases encompass dengue, Chagas disease, leprosy, lymphatic filariasis, and many others. The market features a spectrum of diagnostic methods, including traditional and advanced molecular techniques. Increasing global health initiatives, rising disease prevalence, and advancements in diagnostic solutions are major factors influencing the market’s growth. Expansion of healthcare infrastructure in developing nations further supports the rising demand for effective diagnosis.
Market Growth Drivers:
The global neglected tropical diseases diagnosis market is driven by several important factors. An increasing incidence of neglected tropical diseases in endemic areas has highlighted the need for rapid and accurate diagnostic tools, thereby fueling demand. Additionally, growing funding from governments and international health organizations aimed at disease control and eradication is boosting screening programs worldwide. Technological progress in molecular diagnostics and point-of-care testing enables faster, more reliable disease detection, especially in remote regions. Expansion of healthcare facilities and increased awareness about neglected tropical diseases also contribute significantly to market growth.
Market Restraints:
Despite promising growth, the market faces some challenges. Limited access to healthcare infrastructure and diagnostic laboratories in remote and low-income areas hampers widespread adoption. The relatively high cost of advanced diagnostic equipment poses affordability issues in underdeveloped regions. Moreover, lack of skilled healthcare professionals trained in disease diagnosis and logistical barriers in deploying testing solutions impact market penetration. Underreporting and social stigma surrounding certain diseases lead to underdiagnosis, which limits the overall market potential.
Market Opportunities:
The neglected tropical diseases diagnosis market holds considerable growth opportunities owing to continuous innovation and increasing investments. The development of affordable, portable, and user-friendly point-of-care diagnostic devices provides an avenue to reach underserved populations. Public-private partnerships and global health initiatives focused on eliminating tropical diseases are opening new avenues for market expansion. Emerging diagnostic technologies, such as multiplex assays capable of detecting multiple diseases simultaneously, offer enhanced efficiency. Integration of digital health technologies and artificial intelligence for disease surveillance and diagnostics is also expected to fuel future growth.
Key Questions Answered in the Report:
- What are the main factors contributing to the growth of the neglected tropical diseases diagnosis market?
- Which regions and diseases exhibit the highest demand for diagnostic services?
- How are advances in diagnostic technologies shaping the market landscape?
- Who are the leading companies in this market, and what strategies do they employ?
- What future trends and projections are expected in this market?
Top players in the neglected tropical diseases diagnosis market, including F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, and Genome Diagnostics Pvt. Ltd., are actively investing in product innovation and expanding their market reach. These companies are developing cost-effective and rapid diagnostic solutions tailored for use in low-resource settings. They focus on strategic collaborations with government agencies, NGOs, and healthcare providers to broaden distribution. Additionally, strengthening supply chains and enhancing the accuracy and usability of diagnostic tools are key strategic priorities to maintain competitiveness.
Companies Covered in This Report:
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- Genome Diagnostics Pvt. Ltd.
- InBios International, Inc.
- ZeptoMetrix
- Oscar Medicare Pvt Ltd.
- Coris BioConcept
- Omega Diagnostics Group PLC
- DiaSys Diagnostic Systems GmbH
- Others
By Disease
- Dengue
- Rabies
- Yaws
- Chikungunya
- Leprosy
- Lymphatic Filariasis
- Buruli Ulcer
- Echinococcosis
- Taeniasis/Cysticercosis
- Dracunculiasis
- Foodborne Trematodiases
- Chagas Disease (American Trypanosomiasis)
- African Trypanosomiasis
- Soil-transmitted Helminth Infections
- Onchocerciasis
- Scabies and Other Ectoparasites
- Schistosomiasis
- Snakebite Envenoming
- Leishmaniasis
- Conventional
- Molecular/Modern
- Centralized
- POC
- Clinical Laboratories
- Hospitals/Clinics
- Home Healthcare
- North America
- Europe
- East Asia
- South Asia and Oceania
- Latin America
- Middle East and Africa
Please Note: It will take 5 business days to complete the report upon order confirmation.
Table of Contents
195 Pages
- 1. Executive Summary
- 1.1. Global Neglected Tropical Diseases Diagnosis Market Snapshot, 2025-2032
- 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
- 1.3. Key Market Trends
- 1.4. Future Market Projections
- 1.5. Premium Market Insights
- 1.6. Industry Developments and Key Market Events
- 1.7. PMR Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Scope and Definition
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Key Trends
- 2.3. Macro-economic Factors
- 2.3.1. Public Health Spending and International Aid
- 2.3.2. Global Health Policy and Regulatory Frameworks
- 2.3.3. Geopolitical Stability and Infrastructure Development
- 2.4. COVID-19 Impact Analysis
- 2.5. Forecast Factors - Relevance and Impact
- 3. Value Added Insights
- 3.1. Diagnostic Method Adoption Analysis
- 3.2. Regulatory Landscape
- 3.3. Value Chain Analysis
- 3.4. PESTLE Analysis
- 3.5. Porter’s Five Force Analysis
- 4. Price Analysis, 2025A
- 4.1. Key Highlights
- 4.2. Key Factors Impacting Service Costs
- 4.3. Pricing Analysis, By Diagnostic Method
- 5. Global Neglected Tropical Diseases Diagnosis Market Outlook
- 5.1. Key Highlights
- 5.1.1. Market Volume (Units) Projections
- 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
- 5.1.3. Absolute $ Opportunity
- 5.2. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast
- 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
- 5.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
- 5.3. Global Neglected Tropical Diseases Diagnosis Market Outlook: Disease
- 5.3.1. Introduction / Key Findings
- 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Disease, 2019-2024
- 5.3.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Disease, 2025-2032
- 5.3.3.1. Dengue
- 5.3.3.2. Rabies
- 5.3.3.3. Yaws
- 5.3.3.4. Chikungunya
- 5.3.3.5. Leprosy
- 5.3.3.6. Lymphatic Filariasis
- 5.3.3.7. Buruli Ulcer
- 5.3.3.8. Echinococcosis
- 5.3.3.9. Taeniasis/Cysticercosis
- 5.3.3.10. Dracunculiasis
- 5.3.3.11. Foodborne Trematodiases
- 5.3.3.12. Chagas Disease (American Trypanosomiasis)
- 5.3.3.13. African Trypanosomiasis
- 5.3.3.14. Soil-transmitted Helminth Infections
- 5.3.3.15. Onchocerciasis
- 5.3.3.16. Scabies and Other Ectoparasites
- 5.3.3.17. Schistosomiasis
- 5.3.3.18. Snakebite Envenoming
- 5.3.3.19. Leishmaniasis
- 5.3.4. Market Attractiveness Analysis: Disease
- 5.4. Global Neglected Tropical Diseases Diagnosis Market Outlook: Diagnostic Method
- 5.4.1. Introduction / Key Findings
- 5.4.2. Historical Market Size (US$ Mn) Analysis, By Diagnostic Method, 2019-2024
- 5.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Method, 2025-2032
- 5.4.3.1. Conventional
- 5.4.3.2. Molecular/Modern
- 5.4.4. Market Attractiveness Analysis: Diagnostic Method
- 5.5. Global Neglected Tropical Diseases Diagnosis Market Outlook: Service Type
- 5.5.1. Introduction / Key Findings
- 5.5.2. Historical Market Size (US$ Mn) Analysis, By Service Type, 2019-2024
- 5.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Service Type, 2025-2032
- 5.5.3.1. Centralized
- 5.5.3.2. POC
- 5.5.4. Market Attractiveness Analysis: Service Type
- 5.6. Global Neglected Tropical Diseases Diagnosis Market Outlook: End Use
- 5.6.1. Introduction / Key Findings
- 5.6.2. Historical Market Size (US$ Mn) Analysis, By End Use, 2019-2024
- 5.6.3. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
- 5.6.3.1. Clinical Laboratories
- 5.6.3.2. Hospitals/Clinics
- 5.6.3.3. Home Healthcare
- 5.6.4. Market Attractiveness Analysis: End Use
- 6. Global Neglected Tropical Diseases Diagnosis Market Outlook: Region
- 6.1. Key Highlights
- 6.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Region, 2019-2024
- 6.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
- 6.3.1. North America
- 6.3.2. Europe
- 6.3.3. East Asia
- 6.3.4. South Asia and Oceania
- 6.3.5. Latin America
- 6.3.6. Middle East & Africa
- 6.4. Market Attractiveness Analysis: Region
- 7. North America Neglected Tropical Diseases Diagnosis Market Outlook
- 7.1. Key Highlights
- 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 7.2.1. By Country
- 7.2.2. By Disease
- 7.2.3. By Diagnostic Method
- 7.2.4. By Service Type
- 7.2.5. By End Use
- 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 7.3.1. U.S.
- 7.3.2. Canada
- 7.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Disease, 2025-2032
- 7.4.1. Dengue
- 7.4.2. Rabies
- 7.4.3. Yaws
- 7.4.4. Chikungunya
- 7.4.5. Leprosy
- 7.4.6. Lymphatic Filariasis
- 7.4.7. Buruli Ulcer
- 7.4.8. Echinococcosis
- 7.4.9. Taeniasis/Cysticercosis
- 7.4.10. Dracunculiasis
- 7.4.11. Foodborne Trematodiases
- 7.4.12. Chagas Disease (American Trypanosomiasis)
- 7.4.13. African Trypanosomiasis
- 7.4.14. Soil-transmitted Helminth Infections
- 7.4.15. Onchocerciasis
- 7.4.16. Scabies and Other Ectoparasites
- 7.4.17. Schistosomiasis
- 7.4.18. Snakebite Envenoming
- 7.4.19. Leishmaniasis
- 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Method, 2025-2032
- 7.5.1. Conventional
- 7.5.2. Molecular/Modern
- 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Service Type, 2025-2032
- 7.6.1. Centralized
- 7.6.2. POC
- 7.7. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
- 7.7.1. Clinical Laboratories
- 7.7.2. Hospitals/Clinics
- 7.7.3. Home Healthcare
- 7.8. Market Attractiveness Analysis
- 8. Europe Neglected Tropical Diseases Diagnosis Market Outlook
- 8.1. Key Highlights
- 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 8.2.1. By Country
- 8.2.2. By Disease
- 8.2.3. By Diagnostic Method
- 8.2.4. By Service Type
- 8.2.5. By End Use
- 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 8.3.1. Germany
- 8.3.2. France
- 8.3.3. U.K.
- 8.3.4. Italy
- 8.3.5. Spain
- 8.3.6. Russia
- 8.3.7. Turkey
- 8.3.8. Rest of Europe
- 8.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Disease, 2025-2032
- 8.4.1. Dengue
- 8.4.2. Rabies
- 8.4.3. Yaws
- 8.4.4. Chikungunya
- 8.4.5. Leprosy
- 8.4.6. Lymphatic Filariasis
- 8.4.7. Buruli Ulcer
- 8.4.8. Echinococcosis
- 8.4.9. Taeniasis/Cysticercosis
- 8.4.10. Dracunculiasis
- 8.4.11. Foodborne Trematodiases
- 8.4.12. Chagas Disease (American Trypanosomiasis)
- 8.4.13. African Trypanosomiasis
- 8.4.14. Soil-transmitted Helminth Infections
- 8.4.15. Onchocerciasis
- 8.4.16. Scabies and Other Ectoparasites
- 8.4.17. Schistosomiasis
- 8.4.18. Snakebite Envenoming
- 8.4.19. Leishmaniasis
- 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Method, 2025-2032
- 8.5.1. Conventional
- 8.5.2. Molecular/Modern
- 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Service Type, 2025-2032
- 8.6.1. Centralized
- 8.6.2. POC
- 8.7. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
- 8.7.1. Clinical Laboratories
- 8.7.2. Hospitals/Clinics
- 8.7.3. Home Healthcare
- 8.8. Market Attractiveness Analysis
- 9. East Asia Neglected Tropical Diseases Diagnosis Market Outlook
- 9.1. Key Highlights
- 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 9.2.1. By Country
- 9.2.2. By Disease
- 9.2.3. By Diagnostic Method
- 9.2.4. By Service Type
- 9.2.5. By End Use
- 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. South Korea
- 9.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Disease, 2025-2032
- 9.4.1. Dengue
- 9.4.2. Rabies
- 9.4.3. Yaws
- 9.4.4. Chikungunya
- 9.4.5. Leprosy
- 9.4.6. Lymphatic Filariasis
- 9.4.7. Buruli Ulcer
- 9.4.8. Echinococcosis
- 9.4.9. Taeniasis/Cysticercosis
- 9.4.10. Dracunculiasis
- 9.4.11. Foodborne Trematodiases
- 9.4.12. Chagas Disease (American Trypanosomiasis)
- 9.4.13. African Trypanosomiasis
- 9.4.14. Soil-transmitted Helminth Infections
- 9.4.15. Onchocerciasis
- 9.4.16. Scabies and Other Ectoparasites
- 9.4.17. Schistosomiasis
- 9.4.18. Snakebite Envenoming
- 9.4.19. Leishmaniasis
- 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Method, 2025-2032
- 9.5.1. Conventional
- 9.5.2. Molecular/Modern
- 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Service Type, 2025-2032
- 9.6.1. Centralized
- 9.6.2. POC
- 9.7. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
- 9.7.1. Clinical Laboratories
- 9.7.2. Hospitals/Clinics
- 9.7.3. Home Healthcare
- 9.8. Market Attractiveness Analysis
- 10. South Asia & Oceania Neglected Tropical Diseases Diagnosis Market Outlook
- 10.1. Key Highlights
- 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 10.2.1. By Country
- 10.2.2. By Disease
- 10.2.3. By Diagnostic Method
- 10.2.4. By Service Type
- 10.2.5. By End Use
- 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 10.3.1. India
- 10.3.2. Southeast Asia
- 10.3.3. ANZ
- 10.3.4. Rest of South Asia & Oceania
- 10.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Disease, 2025-2032
- 10.4.1. Dengue
- 10.4.2. Rabies
- 10.4.3. Yaws
- 10.4.4. Chikungunya
- 10.4.5. Leprosy
- 10.4.6. Lymphatic Filariasis
- 10.4.7. Buruli Ulcer
- 10.4.8. Echinococcosis
- 10.4.9. Taeniasis/Cysticercosis
- 10.4.10. Dracunculiasis
- 10.4.11. Foodborne Trematodiases
- 10.4.12. Chagas Disease (American Trypanosomiasis)
- 10.4.13. African Trypanosomiasis
- 10.4.14. Soil-transmitted Helminth Infections
- 10.4.15. Onchocerciasis
- 10.4.16. Scabies and Other Ectoparasites
- 10.4.17. Schistosomiasis
- 10.4.18. Snakebite Envenoming
- 10.4.19. Leishmaniasis
- 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Method, 2025-2032
- 10.5.1. Conventional
- 10.5.2. Molecular/Modern
- 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Service Type, 2025-2032
- 10.6.1. Centralized
- 10.6.2. POC
- 10.7. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
- 10.7.1. Clinical Laboratories
- 10.7.2. Hospitals/Clinics
- 10.7.3. Home Healthcare
- 10.8. Market Attractiveness Analysis
- 11. Latin America Neglected Tropical Diseases Diagnosis Market Outlook
- 11.1. Key Highlights
- 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 11.2.1. By Country
- 11.2.2. By Disease
- 11.2.3. By Diagnostic Method
- 11.2.4. By Service Type
- 11.2.5. By End Use
- 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 11.3.1. Brazil
- 11.3.2. Mexico
- 11.3.3. Rest of Latin America
- 11.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Disease, 2025-2032
- 11.4.1. Dengue
- 11.4.2. Rabies
- 11.4.3. Yaws
- 11.4.4. Chikungunya
- 11.4.5. Leprosy
- 11.4.6. Lymphatic Filariasis
- 11.4.7. Buruli Ulcer
- 11.4.8. Echinococcosis
- 11.4.9. Taeniasis/Cysticercosis
- 11.4.10. Dracunculiasis
- 11.4.11. Foodborne Trematodiases
- 11.4.12. Chagas Disease (American Trypanosomiasis)
- 11.4.13. African Trypanosomiasis
- 11.4.14. Soil-transmitted Helminth Infections
- 11.4.15. Onchocerciasis
- 11.4.16. Scabies and Other Ectoparasites
- 11.4.17. Schistosomiasis
- 11.4.18. Snakebite Envenoming
- 11.4.19. Leishmaniasis
- 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Method, 2025-2032
- 11.5.1. Conventional
- 11.5.2. Molecular/Modern
- 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Service Type, 2025-2032
- 11.6.1. Centralized
- 11.6.2. POC
- 11.7. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
- 11.7.1. Clinical Laboratories
- 11.7.2. Hospitals/Clinics
- 11.7.3. Home Healthcare
- 11.8. Market Attractiveness Analysis
- 12. Middle East & Africa Neglected Tropical Diseases Diagnosis Market Outlook
- 12.1. Key Highlights
- 12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 12.2.1. By Country
- 12.2.2. By Disease
- 12.2.3. By Diagnostic Method
- 12.2.4. By Service Type
- 12.2.5. By End Use
- 12.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 12.3.1. GCC Countries
- 12.3.2. Egypt
- 12.3.3. South Africa
- 12.3.4. Northern Africa
- 12.3.5. Rest of Middle East & Africa
- 12.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Disease, 2025-2032
- 12.4.1. Dengue
- 12.4.2. Rabies
- 12.4.3. Yaws
- 12.4.4. Chikungunya
- 12.4.5. Leprosy
- 12.4.6. Lymphatic Filariasis
- 12.4.7. Buruli Ulcer
- 12.4.8. Echinococcosis
- 12.4.9. Taeniasis/Cysticercosis
- 12.4.10. Dracunculiasis
- 12.4.11. Foodborne Trematodiases
- 12.4.12. Chagas Disease (American Trypanosomiasis)
- 12.4.13. African Trypanosomiasis
- 12.4.14. Soil-transmitted Helminth Infections
- 12.4.15. Onchocerciasis
- 12.4.16. Scabies and Other Ectoparasites
- 12.4.17. Schistosomiasis
- 12.4.18. Snakebite Envenoming
- 12.4.19. Leishmaniasis
- 12.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Method, 2025-2032
- 12.5.1. Conventional
- 12.5.2. Molecular/Modern
- 12.6. Current Market Size (US$ Mn) Analysis and Forecast, By Service Type, 2025-2032
- 12.6.1. Centralized
- 12.6.2. POC
- 12.7. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
- 12.7.1. Clinical Laboratories
- 12.7.2. Hospitals/Clinics
- 12.7.3. Home Healthcare
- 12.8. Market Attractiveness Analysis
- 13. Competition Landscape
- 13.1. Market Share Analysis, 2025
- 13.2. Market Structure
- 13.2.1. Competition Intensity Mapping By Market
- 13.2.2. Competition Dashboard
- 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 13.3.1. F. Hoffmann-La Roche Ltd
- 13.3.1.1. Overview
- 13.3.1.2. Segments and Diseases
- 13.3.1.3. Key Financials
- 13.3.1.4. Market Developments
- 13.3.1.5. Market Strategy
- 13.3.2. Thermo Fisher Scientific Inc.
- 13.3.3. Abbott Laboratories
- 13.3.4. Genome Diagnostics Pvt. Ltd.
- 13.3.5. InBios International, Inc.
- 13.3.6. ZeptoMetrix
- 13.3.7. Oscar Medicare Pvt Ltd.
- 13.3.8. Coris BioConcept
- 13.3.9. Omega Diagnostics Group PLC
- 13.3.10. DiaSys Diagnostic Systems GmbH
- 13.3.11. Others
- 14. Appendix
- 14.1. Research Methodology
- 14.2. Research Assumptions
- 14.3. Acronyms and Abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
